Literature DB >> 19439414

A functional and structural study of troponin C mutations related to hypertrophic cardiomyopathy.

Jose Renato Pinto1, Michelle S Parvatiyar, Michelle A Jones, Jingsheng Liang, Michael J Ackerman, James D Potter.   

Abstract

Recently four new hypertrophic cardiomyopathy mutations in cardiac troponin C (cTnC) (A8V, C84Y, E134D, and D145E) were reported, and their effects on the Ca(2+) sensitivity of force development were evaluated (Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ommen, S. R., Potter, J. D., and Ackerman, M. J. (2008) J. Mol. Cell. Cardiol. 45, 281-288). We performed actomyosin ATPase and spectroscopic solution studies to investigate the molecular properties of these mutations. Actomyosin ATPase activity was measured as a function of [Ca(2+)] utilizing reconstituted thin filaments (TFs) with 50% mutant and 50% wild type (WT) and 100% mutant cardiac troponin (cTn) complexes: A8V, C84Y, and D145E increased the Ca(2+) sensitivity with only A8V demonstrating lowered Ca(2+) sensitization at the 50% ratio when compared with 100%; E134D was the same as WT at both ratios. Of these four mutants, only D145E showed increased ATPase activation in the presence of Ca(2+). None of the mutants affected ATPase inhibition or the binding of cTn to the TF measured by co-sedimentation. Only D145E increased the Ca(2+) affinity of site II measured by 2-(4'-(2''-iodoacetamido)phenyl)aminonaphthalene-6-sulfonic acid fluorescence in isolated cTnC or the cTn complex. In the presence of the TF, only A8V was further sensitized to Ca(2+). Circular dichroism measurements in different metal-bound states of the isolated cTnCs showed changes in the secondary structure of A8V, C84Y, and D145E, whereas E134D was the same as WT. PyMol modeling of each cTnC mutant within the cTn complex revealed potential for local changes in the tertiary structure of A8V, C84Y, and D145E. Our results indicate that 1) three of the hypertrophic cardiomyopathy cTnC mutants increased the Ca(2+) sensitivity of the myofilament; 2) the effects of the mutations on the Ca(2+) affinity of isolated cTnC, cTn, and TF are not sufficient to explain the large Ca(2+) sensitivity changes seen in reconstituted and fiber assays; and 3) changes in the secondary structure of the cTnC mutants may contribute to modified protein-protein interactions along the sarcomere lattice disrupting the coupling between the cross-bridge and Ca(2+) binding to cTnC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439414      PMCID: PMC2707221          DOI: 10.1074/jbc.M109.007021

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Crystal structure of troponin C in complex with troponin I fragment at 2.3-A resolution.

Authors:  D G Vassylyev; S Takeda; S Wakatsuki; K Maeda; Y Maéda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

2.  Steric-model for activation of muscle thin filaments.

Authors:  P Vibert; R Craig; W Lehman
Journal:  J Mol Biol       Date:  1997-02-14       Impact factor: 5.469

3.  The role of the four Ca2+ binding sites of troponin C in the regulation of skeletal muscle contraction.

Authors:  D Szczesna; G Guzman; T Miller; J Zhao; K Farokhi; H Ellemberger; J D Potter
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

Review 4.  Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death.

Authors:  A J Marian; R Roberts
Journal:  J Cardiovasc Electrophysiol       Date:  1998-01

Review 5.  Molecular genetics and genomics of heart failure.

Authors:  Choong-Chin Liew; Victor J Dzau
Journal:  Nat Rev Genet       Date:  2004-11       Impact factor: 53.242

Review 6.  Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene.

Authors:  Aldrin V Gomes; James D Potter
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

7.  Fluorescent probes attached to Cys 35 or Cys 84 in cardiac troponin C are differentially sensitive to Ca(2+)-dependent events in vitro and in situ.

Authors:  J A Putkey; W Liu; X Lin; S Ahmed; M Zhang; J D Potter; W G Kerrick
Journal:  Biochemistry       Date:  1997-01-28       Impact factor: 3.162

8.  Structural details of a calcium-induced molecular switch: X-ray crystallographic analysis of the calcium-saturated N-terminal domain of troponin C at 1.75 A resolution.

Authors:  N C Strynadka; M Cherney; A R Sielecki; M X Li; L B Smillie; M N James
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

9.  Mutations in the N- and D-helices of the N-domain of troponin C affect the C-domain and regulatory function.

Authors:  L Smith; N J Greenfield; S E Hitchcock-DeGregori
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

10.  Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C.

Authors:  R Zhang; J Zhao; J D Potter
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

View more
  48 in total

1.  Hypertrophic cardiomyopathy-linked mutation D145E drastically alters calcium binding by the C-domain of cardiac troponin C.

Authors:  Nicholas Swindle; Svetlana B Tikunova
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

Review 2.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

3.  Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

Authors:  Jose Renato Pinto; Jill D Siegfried; Michelle S Parvatiyar; Duanxiang Li; Nadine Norton; Michelle A Jones; Jingsheng Liang; James D Potter; Ray E Hershberger
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

4.  Allosteric Transmission along a Loosely Structured Backbone Allows a Cardiac Troponin C Mutant to Function with Only One Ca2+ Ion.

Authors:  Mayra de A Marques; Jose Renato Pinto; Adolfo H Moraes; Anwar Iqbal; Mariana T Q de Magalhães; Jamila Monteiro; Murilo M Pedrote; Martha M Sorenson; Jerson L Silva; Guilherme A P de Oliveira
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

Review 5.  Molecular genetics and pathogenesis of cardiomyopathy.

Authors:  Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

6.  Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto
Journal:  Biochim Biophys Acta       Date:  2014-11-01

7.  Stepwise C-Terminal Truncation of Cardiac Troponin T Alters Function at Low and Saturating Ca2.

Authors:  Dylan Johnson; C William Angus; Joseph M Chalovich
Journal:  Biophys J       Date:  2018-07-12       Impact factor: 4.033

8.  Molecular Dynamics and Umbrella Sampling Simulations Elucidate Differences in Troponin C Isoform and Mutant Hydrophobic Patch Exposure.

Authors:  Jacob D Bowman; Steffen Lindert
Journal:  J Phys Chem B       Date:  2018-08-02       Impact factor: 2.991

9.  Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.

Authors:  Henry G Zot; Javier E Hasbun; Clara A Michell; Maicon Landim-Vieira; Jose R Pinto
Journal:  Arch Biochem Biophys       Date:  2016-03-11       Impact factor: 4.013

10.  S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.

Authors:  Tomoya Irie; Patrick Y Sips; Shinichi Kai; Kotaro Kida; Kohei Ikeda; Shuichi Hirai; Kasra Moazzami; Pawina Jiramongkolchai; Donald B Bloch; Paschalis-Thomas Doulias; Antonis A Armoundas; Masao Kaneki; Harry Ischiropoulos; Evangelia Kranias; Kenneth D Bloch; Jonathan S Stamler; Fumito Ichinose
Journal:  Circ Res       Date:  2015-08-10       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.